New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients
|
By IntellAsia: Resources
on 9/14/2021
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more than 20 years ZEPZELCA approval granted under a provisional regulatory pathway ...
Full "IntellAsia: Resources" article
|
|